這個就是早些時候俺提到的抗體。臨床試驗已經在三期，前幾天有報道。見內

https://investor.regeneron.com/news-releases/news-release-details/regenerons-regn-cov2-antibody-cocktail-reduced-viral-levels-and

 

REGENERON'S REGN-COV2 ANTIBODY COCKTAIL REDUCED VIRAL LEVELS AND IMPROVED SYMPTOMS IN NON-HOSPITALIZED COVID-19 PATIENTS

TARRYTOWN, N.Y., Sept. 29, 2020 /PRNewswire/ --  

Greatest improvements in patients who had not mounted their own effective immune response prior to treatment

…………、

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the first data from a descriptive analysis of a seamless Phase 1/2/3 trial of its investigational antibody cocktail REGN-COV2 showing it reduced viral load and the time to alleviate symptoms in non-hospitalized patients with COVID-19. REGN-COV2 also showed positive trends in reducing medical visits. The ongoing, randomized, double-blind trial measures the effect of adding REGN-COV2 to usual standard-of-care, compared to adding placebo to standard-of-care. 

………、.。

About REGN-COV2
REGN-COV2 is a combination of two monoclonal antibodies (REGN10933 and REGN10987) and was designed specifically to block infectivity of SARS-CoV-2, the virus that causes COVID-19.

 

 

 

 

所有跟帖： 

• for Covid 19, only phase 1. less than 300 participated .LOL -老玩家- ♂ (0 bytes) () 10/02/2020 postreply 13:50:52

• “在”是進行時。 -fuz- ♂ (1183 bytes) () 10/02/2020 postreply 14:02:31

• 在美國COVID 19 隻完成了PHASE 1，前CDC老板剛在電視上說了。LOL -老玩家- ♂ (0 bytes) () 10/02/2020 postreply 14:10:53